DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Herceptin (Trastuzumab) - Febrile Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Febrile Neutropenia (63)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Herceptin (Trastuzumab) where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 63   Next >>

Possible Herceptin side effects in female

Reported by a physician from France on 2012-08-17

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Mucosal Inflammation, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: date of last dose prior to sae: 01/aug/2012
    Indication: Breast Cancer
    Start date: 2012-08-01

Docetaxel
    Dosage: date of last dose prior to sae : 01/aug/2012
    Indication: Breast Cancer
    Start date: 2012-08-01

Blinded Pertuzumab
    Dosage: date of last dose rpior to sae: 01/aug/2012
    Indication: Breast Cancer
    Start date: 2012-08-01

Other drugs received by patient: Tramadol HCL; Zofran; Acetaminophen; Fluconazole; Solu-Medrol



Possible Herceptin side effects in female

Reported by a physician from Korea, Republic of on 2012-08-15

Patient: female, weighing 47.9 kg (105.4 pounds)

Reactions: Mucosal Inflammation, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Cisplatin
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Pertuzumab
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Xeloda
    Dosage: date of last dose prior to sae: 28/jun/2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-29

Other drugs received by patient: Palonosetron; Chlorpheniramine Maleate; Ircodon; Loperamide; Levofloxacin; Levofloxacin; Potassium Chloride; Spironolactone; Meropenem; Nystatin; Calcium Gluconate; Alginate Sodium; Mannitol; Metoclopramide; Furosemide; Gynobetadine; Meperidine HCL; Chlorhexidine Gluconate; Megestrol Acetate; Fentanyl; Famotidine; Potassium Dihydrogen Phosphate; Ketorolac; Dexamethasone; Pantoprazole; Albuminar-20; Meropenem; Oxytetracycline HCL; Polymyxin B Sulfate; Norepinephrine; Tetracosactrin; Almagate; Calcium Pantothenate / Cyanocobalamin / Nicotinamide / Pyridoxine Hydrochlor; Aprepitant; Aprepitant; Acetaminophen; Povidone Iodine; Pantoprazole; Pantoprazole; Morphine Sulfate; Metronidazole; Levofloxacin; Esomeprazole; Albuminar-20; Albuminar-20; Calcium Citrate with Vitamin D3; Ambroxol; Ondansetron; Dried Ferrous Sulfate; Dexamethasone; Magnesium Sulfate; Morphine Sulfate; Metoclopramide; Ambroxol; Filgrastim; Nicotinamide / Pyridoxine Hydrochloride / Riboflavin / Thiamine Hydrochlorid; Ircodon; Povidone Iodine; Mupirocin; Metronidazole; Levofloxacin; Ondansetron; Combiflex (Unk Ingredients); Metronidazole; Metronidazole; Potassium Chloride; Furosemide; Morphine HCL; Sodium Bicarbonate



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-15

Patient: female, weighing 57.6 kg (126.7 pounds)

Reactions: Abdominal Pain, Diarrhoea, Disseminated Intravascular Coagulation, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: permanently discontinued
    End date: 2012-05-25

Docetaxel
    Dosage: permanently discontinued
    End date: 2012-05-25

Pertuzumab
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-25

Docetaxel
    Dosage: permanently discontinued
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-04

Carboplatin
    Dosage: permanently discontinued
    End date: 2012-05-25

Herceptin
    Dosage: maintanance dose, temporarily interrupted
    End date: 2012-05-04

Carboplatin
    Dosage: temporarily discontinued
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-04

Herceptin
    Dosage: loading dose, permanently discontinued
    Indication: Breast Cancer
    Start date: 2012-04-13

Other drugs received by patient: Clindamycin; Lovaza; Tylenol; Zofran



Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-08-03

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Febrile Neutropenia, Duodenal Ulcer, Hepatic Failure, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Mucosta; Fluconazole; Acetaminophen; Tinzaparin; Tranexamic Acid; Omeprazole; Ciprofloxacin; Vitamin K TAB



Possible Herceptin side effects in female

Reported by a physician from Korea, Republic of on 2012-08-01

Patient: female, weighing 47.9 kg (105.4 pounds)

Reactions: Mucosal Inflammation, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pertuzumab
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Xeloda
    Dosage: date of last dose prior to sae: 28/jun/2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-29

Herceptin
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Cisplatin
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29



Possible Herceptin side effects in female

Reported by a physician from Korea, Republic of on 2012-07-31

Patient: female, weighing 47.9 kg (105.4 pounds)

Reactions: Mucosal Inflammation, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Pertuzumab
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Cisplatin
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Xeloda
    Dosage: date of last dose prior to sae: 28/jun/2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-29



Possible Herceptin side effects in

Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-19

Patient:

Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite

Drug(s) suspected as cause:
Gemcitabine Hydrochloride
    Dosage: on days 1 and 8 every 21 days
    Indication: Breast Cancer

Herceptin
    Dosage: within 2 weeks after curative surgery until 52 weeks of therapy was completed

Paclitaxel
    Dosage: over 1 h on days 1 and 8 every 21 days
    Indication: Breast Cancer

Herceptin
    Dosage: over 90 min on day 1
    Indication: Breast Cancer

Herceptin
    Dosage: over 30 min weekly



Possible Herceptin side effects in

Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-18

Patient:

Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Decreased Appetite, Leukopenia

Drug(s) suspected as cause:
Paclitaxel
    Indication: Breast Cancer

Paclitaxel
    Dosage: dosages were modified to one step lower than the previous level after withholding treatment

Gemcitabine Hydrochloride
    Indication: Breast Cancer

Herceptin
    Dosage: over 90 min on day 1, followed by 2 mg/kg over 30 min weekly, for a total of 18 doses
    Indication: Breast Cancer

Herceptin
    Dosage: after curative surgery until 52 weeks of therapy was completed.

Gemcitabine Hydrochloride
    Dosage: dosages were modified to one step lower than the previous level after withholding treatment



Possible Herceptin side effects in female

Reported by a physician from Korea, Democratic People's Republic of on 2012-07-16

Patient: female, weighing 47.9 kg (105.4 pounds)

Reactions: Mucosal Inflammation, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Herceptin
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Pertuzumab
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Xeloda
    Dosage: date of last dose prior to sae: 28/jun/2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-29



Possible Herceptin side effects in female

Reported by a physician from Spain on 2012-07-12

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Mucosal Inflammation, Diarrhoea, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Pertuzumab
    Dosage: maintanance dose, last dose prior to sae:11/jun/2012

Herceptin
    Dosage: maintanance dose, last dose prior to sae:11/jun/2012

Docetaxel
    Dosage: last dose prior to sae:11/jun/2012
    Indication: Breast Cancer
    Start date: 2012-04-30

Blinded Pertuzumab
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-30

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-30

Other drugs received by patient: Insulin; Bromazepam; Acetaminophen; Venlafaxine; Enalapril Maleate; Omeprazole; Gliclazide; Gemfibrozil; Metformin HCL; Atorvastan



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Spain on 2012-07-02

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Mucosal Inflammation, Diarrhoea, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Pertuzumab
    Dosage: maintanance dose, last dose prior to sae:11/jun/2012

Blinded Pertuzumab
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-30

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-30

Herceptin
    Dosage: maintanance dose, last dose prior to sae:11/jun/2012

Docetaxel
    Dosage: last dose prior to sae:11/jun/2012
    Indication: Breast Cancer
    Start date: 2012-04-30

Other drugs received by patient: Paracetamol; Omeprazole; Enalapril Maleate; Gemfibrozil; Insulin; Atorvastan; Bromazepam; Metformin HCL; Gliclazide; Loperamide; Venlafaxine



Possible Herceptin side effects in female

Reported by a physician from Belgium on 2012-06-29

Patient: female, weighing 66.0 kg (145.2 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Taxotere
    Dosage: 100mg cyclic
    Indication: Breast Cancer
    Start date: 2012-06-06

Tyverb
    Dosage: 1000mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-06-06

Herceptin
    Dosage: 130mg cyclic
    Indication: Breast Cancer
    Start date: 2012-06-06



Possible Herceptin side effects in female

Reported by a physician from Belgium on 2012-06-21

Patient: female, weighing 66.0 kg (145.2 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lapatinib
    Dosage: 1000mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-06-06

Herceptin
    Indication: Breast Cancer
    Start date: 2012-06-06

Taxotere
    Dosage: 100mg cyclic
    Indication: Breast Cancer
    Start date: 2012-06-06



Possible Herceptin side effects in

Reported by a individual with unspecified qualification from United States on 2012-06-19

Patient:

Reactions: Thrombosis, Headache, Device Related Infection, Peripheral Sensory Neuropathy, Pericardial Effusion, Malaise, Dyspepsia, Granulocytopenia, Hypoxia, Pneumonitis, Blood Alkaline Phosphatase Increased, Hypotension, Anaemia, Hyperglycaemia, Dehydration, Neutropenia, Pain, Bone Pain, Hypokalaemia, Neutropenic Infection, Postoperative Wound Infection, Fatigue, Chest Pain, Depression, Lethargy, Vomiting, Dyspnoea, Lymphopenia, Alanine Aminotransferase Increased, Muscular Weakness, Febrile Neutropenia, Hypophosphataemia, Syncope, Arthralgia, Diarrhoea, Ejection Fraction Decreased, Hypermagnesaemia, Respiratory Tract Infection, Leukopenia, Infection

Drug(s) suspected as cause:
Vinorelbine Tartrate
    Dosage: on day 8 and 15 of the 21 days cycle
    Indication: Breast Cancer Metastatic

Herceptin

Docetaxel
    Indication: Breast Cancer Metastatic

Herceptin
    Indication: Breast Cancer Metastatic



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Spain on 2012-06-15

Patient: female, weighing 69.0 kg (151.8 pounds)

Reactions: Mucosal Inflammation, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: maintanance dose

Blinded Pertuzumab
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-30

Blinded Pertuzumab
    Dosage: maintanance dose

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-30

Docetaxel
    Indication: Breast Cancer
    Start date: 2012-04-30

Other drugs received by patient: Insulin; Gemfibrozil; Enalapril Maleate; Atorvastan; Bromazepam; Metformin HCL; Omeprazole; Gliclazide; Acetaminophen; Venlafaxine HCL



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Philippines on 2012-06-15

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Duodenal Ulcer, Hepatic Failure, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Docetaxel
    Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Acetaminophen; Vitamin K TAB; Fluconazole; Mucosta; Ciproflaxacin; Omeprazole; Tranexamic Acid; Tinzaparin



Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-06-08

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Hepatic Failure, Duodenal Ulcer, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Ciprofloxacin; Acetaminophen; Mucosta; Omeprazole; Fluconazole; Vitamin K TAB; Tinzaparin; Tranexamic Acid



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Philippines on 2012-06-08

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Duodenal Ulcer, Hepatic Failure, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Ciprofloxacin; Fluconazole; Tinzaparin; Acetaminophen; Omeprazole; Mucosta; Tranexamic Acid; Vitamin K TAB



Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-06-07

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Pneumonia, Cardio-Respiratory Arrest, Hepatic Failure, Febrile Neutropenia, Duodenal Ulcer, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Omeprazole; Ciprofloxacin; Fluconazole; Acetaminophen; Tinzaparin; Vitamin K TAB; Mucosta; Tranexamic Acid



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-05-31

Patient: female, weighing 57.6 kg (126.7 pounds)

Reactions: Diarrhoea, Disseminated Intravascular Coagulation, Sepsis, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Docetaxel
    Dosage: temporarily interrupted
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-04

Herceptin
    Dosage: loading dose, temporarily interrupted
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-04

Carboplatin
    Indication: Breast Cancer
    Start date: 2012-04-13

Pertuzumab
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-13

Other drugs received by patient: Zofran; Lovaza; Tylenol; Clindamycin



Possible Herceptin side effects in

Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-05-30

Patient:

Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite

Drug(s) suspected as cause:
Paclitaxel
    Dosage: dosages were modified to one step lower than the previous level after withholding treatment

Gemcitabine Hydrochloride
    Indication: Breast Cancer

Herceptin
    Dosage: over 90 min on day 1, followed by 2 mg/kg over 30 min weekly, for a total of 18 doses
    Indication: Breast Cancer

Herceptin
    Dosage: after curative surgery until 52 weeks of therapy was completed.

Paclitaxel
    Indication: Breast Cancer

Gemcitabine Hydrochloride
    Dosage: dosages were modified to one step lower than the previous level after withholding treatment



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Canada on 2012-05-24

Patient: female, weighing 73.1 kg (160.8 pounds)

Reactions: Death, Dehydration, Oedema, Febrile Neutropenia, Staphylococcal Bacteraemia, Asthenia, Epistaxis, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: loading dose
    Start date: 2011-09-16

Docetaxel
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-01

Herceptin
    Start date: 2011-10-07

Herceptin
    Indication: Breast Cancer Metastatic
    Start date: 2008-01-01

Herceptin
    Start date: 2012-01-06

Docetaxel
    Start date: 2011-09-16
    End date: 2012-01-06

Other drugs received by patient: Metformin HCL; Hydromorphone HCL; Synthroid; Prochlorperazine; Zofran; Prevacid; Decadron; Crestor; Domperidone; Lyrica; Diamicron; Nystatin



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-05-16

Patient: female, weighing 86.0 kg (189.2 pounds)

Reactions: Dyspnoea, Diarrhoea, Sepsis, Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Docetaxel
    Dosage: form: vials, dose level: 60 mg/m2, dose reduced.
    Indication: Breast Cancer

Herceptin
    Dosage: form: vials, dose level: 6 mg/kg,permanently discontinued
    Indication: Breast Cancer
    Start date: 2010-05-04
    End date: 2010-07-22

Carboplatin
    Dosage: form: vials, dose level 5 auc, dose reduced.
    Indication: Breast Cancer

Carboplatin
    Start date: 2010-06-15
    End date: 2010-07-22

Docetaxel
    Start date: 2010-06-15
    End date: 2010-07-22

Other drugs received by patient: Dexamethasone; Cellondan; Metoclopramide; Bisoprolol Fumarate; Loperamide; Emend



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-05-14

Patient: female, weighing 84.0 kg (184.8 pounds)

Reactions: Cardiac Failure, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: reported as adriamycin
    Indication: Breast Cancer
    Start date: 2011-09-21
    End date: 2011-10-14

Paclitaxel
    Indication: Breast Cancer
    Start date: 2011-11-04
    End date: 2012-01-01

Herceptin
    Indication: Breast Cancer
    Start date: 2011-11-04
    End date: 2012-01-01

Cyclophosphamide
    Dosage: reported as cytoxan
    Indication: Breast Cancer
    Start date: 2011-09-21
    End date: 2011-10-14



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-05-01

Patient: female, weighing 57.6 kg (126.7 pounds)

Reactions: Diarrhoea, Sepsis, Disseminated Intravascular Coagulation, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Docetaxel
    Indication: Breast Cancer
    Start date: 2012-04-13

Carboplatin
    Indication: Breast Cancer
    Start date: 2012-04-13

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-13

Pertuzumab
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-13

Other drugs received by patient: Lovaza; Clindamycin; Tylenol (Caplet); Zofran



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-04-23

Patient: female

Reactions: Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer Metastatic
    Start date: 2005-10-21

Ixabepilone
    Indication: Breast Cancer Metastatic
    Start date: 2005-10-21

Carboplatin
    Start date: 2005-10-28

Herceptin
    Indication: Breast Cancer Metastatic
    Start date: 2005-10-21

Herceptin



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-04-19

Patient: female, weighing 84.0 kg (184.8 pounds)

Reactions: Cardiac Failure, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    Start date: 2011-11-04
    End date: 2012-01-01

Paclitaxel
    Indication: Breast Cancer
    Start date: 2011-11-04
    End date: 2012-01-01



Possible Herceptin side effects in male

Reported by a individual with unspecified qualification from Japan on 2012-04-13

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: White Blood Cell Count Decreased, Stomatitis, Renal Disorder, Pain, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Pyrexia, Constipation, Haemoglobin Decreased, Malaise, Platelet Count Decreased, Hiccups, Neutrophil Count Decreased, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 60mg-120mg
    Indication: Gastric Cancer Recurrent
    Start date: 2011-04-14
    End date: 2011-09-21

Xeloda
    Dosage: 2 weeks administration followed by 1 week rest
    Administration route: Oral
    Start date: 2011-08-03

Xeloda
    Dosage: 2 weeks administration followed by 1 week rest
    Administration route: Oral
    Indication: Gastric Cancer Recurrent
    Start date: 2011-04-14
    End date: 2011-07-06

Herceptin
    Start date: 2011-05-11
    End date: 2011-06-22

Herceptin
    Start date: 2011-08-03

Herceptin
    Indication: Gastric Cancer Recurrent
    Start date: 2011-04-14
    End date: 2011-04-14

Other drugs received by patient: Loperamide HCL; Emend; Decadron; Granisetron; Allopurinol; Voltaren; Gosha-Jinki-GAN; Emend; Hydrocortisone Sodium Succinate; Emend; Dexamethasone Sodium Phosphate



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Philippines on 2012-04-10

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Febrile Neutropenia, Duodenal Ulcer, Hepatic Failure, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Fluconazole; Tinzaparin; Vitamin K TAB; Ciprofloxacin Hydrochloride; Omeprazole; Mucosta



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Philippines on 2012-04-05

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Hepatic Failure, Duodenal Ulcer, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Vitamin K TAB; Mucosta; Fluconazole; Tinzaparin; Omeprazole; Ciprofloxacin



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017